Tilray Brands, Inc. Common Stock TLRY
i
Market dataready · fetched 2026-11-10T22:18:03.548Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T22:14:28.906316073Z
FundamentalsSEC EDGAR · ready · as of 2026-08-31 · fetched 2026-11-10T22:18:03.180469+00:00
Tilray Brands, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.94 | 106.3% | 11.9% | 2.53 | 73.3% | 6.2% |
| 25Δ | 2.90 | 104.7% | 11.0% | 2.56 | 75.0% | 5.8% |
| 30Δ | 2.87 | 103.1% | 10.1% | 2.59 | 76.8% | 5.4% |
| 35Δ | 2.83 | 101.5% | 9.2% | 2.63 | 78.5% | 5.0% |
| 40Δ | 2.79 | 99.9% | 8.2% | 2.66 | 80.2% | 4.6% |
| 45Δ | 2.76 | 98.3% | 7.3% | 2.69 | 81.9% | 4.1% |
| 50Δ | 2.72 | 96.7% | 6.4% | 2.73 | 83.6% | 3.7% |
| 55Δ | 2.68 | 95.1% | 5.5% | 2.76 | 85.3% | 3.3% |
| 60Δ | 2.64 | 93.5% | 4.6% | 2.79 | 87.0% | 2.9% |
| 65Δ | 2.61 | 91.9% | 3.6% | 2.83 | 88.7% | 2.5% |
| 70Δ | 2.57 | 90.3% | 2.7% | 2.86 | 90.5% | 2.1% |
| 75Δ | 2.53 | 88.7% | 1.8% | 2.90 | 92.2% | 1.6% |
| 80Δ | 2.93 | 93.9% | 1.2% | |||
20Δ
- Pseudo strike
- 2.94
- IV
- 106.3%
- B/E move
- 11.9%
- Pseudo strike
- 2.53
- IV
- 73.3%
- B/E move
- 6.2%
25Δ
- Pseudo strike
- 2.90
- IV
- 104.7%
- B/E move
- 11.0%
- Pseudo strike
- 2.56
- IV
- 75.0%
- B/E move
- 5.8%
30Δ
- Pseudo strike
- 2.87
- IV
- 103.1%
- B/E move
- 10.1%
- Pseudo strike
- 2.59
- IV
- 76.8%
- B/E move
- 5.4%
35Δ
- Pseudo strike
- 2.83
- IV
- 101.5%
- B/E move
- 9.2%
- Pseudo strike
- 2.63
- IV
- 78.5%
- B/E move
- 5.0%
40Δ
- Pseudo strike
- 2.79
- IV
- 99.9%
- B/E move
- 8.2%
- Pseudo strike
- 2.66
- IV
- 80.2%
- B/E move
- 4.6%
45Δ
- Pseudo strike
- 2.76
- IV
- 98.3%
- B/E move
- 7.3%
- Pseudo strike
- 2.69
- IV
- 81.9%
- B/E move
- 4.1%
50Δ
- Pseudo strike
- 2.72
- IV
- 96.7%
- B/E move
- 6.4%
- Pseudo strike
- 2.73
- IV
- 83.6%
- B/E move
- 3.7%
55Δ
- Pseudo strike
- 2.68
- IV
- 95.1%
- B/E move
- 5.5%
- Pseudo strike
- 2.76
- IV
- 85.3%
- B/E move
- 3.3%
60Δ
- Pseudo strike
- 2.64
- IV
- 93.5%
- B/E move
- 4.6%
- Pseudo strike
- 2.79
- IV
- 87.0%
- B/E move
- 2.9%
65Δ
- Pseudo strike
- 2.61
- IV
- 91.9%
- B/E move
- 3.6%
- Pseudo strike
- 2.83
- IV
- 88.7%
- B/E move
- 2.5%
70Δ
- Pseudo strike
- 2.57
- IV
- 90.3%
- B/E move
- 2.7%
- Pseudo strike
- 2.86
- IV
- 90.5%
- B/E move
- 2.1%
75Δ
- Pseudo strike
- 2.53
- IV
- 88.7%
- B/E move
- 1.8%
- Pseudo strike
- 2.90
- IV
- 92.2%
- B/E move
- 1.6%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.93
- IV
- 93.9%
- B/E move
- 1.2%
Options history
Table
| Date | IV (%) |
|---|---|
| 93.34% | |
| 84.55% | |
| 133.65% | |
| 197.72% | |
| 90.89% | |
| 155.90% | |
| 180.55% | |
| 117.04% | |
| 162.29% | |
| 163.33% | |
| 135.80% | |
| 84.95% | |
| 214.86% | |
| 159.32% | |
| 99.98% | |
| 199.68% | |
| 106.81% | |
| 197.30% | |
| 114.61% | |
| 214.81% | |
| 272.45% | |
| 342.94% | |
| 254.30% | |
| 273.47% | |
| 340.88% | |
| 278.77% |
Drug Manufacturers - Specialty & Generic
TRLV
Trulieve Cannabis Corp. (TRLV) is a prominent player in the US cannabis market, distinguished by its comprehensive vertical integration that encompasses cultivation, production,…
More →TXMD
TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
More →UTHR
Description unavailable
More →VTRS
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
More →XERS
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in…
More →ZTS
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
More →